Level and Duration of IgG and Neutralizing Antibodies to SARS-CoV-2 in Children with Symptomatic or Asymptomatic SARS-CoV-2 Infection (original) (raw)
Caitlin Bond
2022, ImmunoHorizons
visibility
…
description
9 pages
link
1 file
Sign up for access to the world's latest research.
checkGet notified about relevant papers
checkSave papers to use in your research
checkJoin the discussion with peers
checkTrack your impact
Antibody Response to SARS-CoV-2 Infection in Non Vaccinated Health Care Personnel
Tanjima Begum
Journal of Bangladesh College of Physicians and Surgeons, 2022
View PDFchevron_right
Role of Anti-SARS-CoV-2 antibodies in different cohorts: Can they provide clues for appropriate patient triaging?
Amin Mohammad
bioRxiv (Cold Spring Harbor Laboratory), 2020
View PDFchevron_right
Prospective serological evaluation of anti SARS-CoV-2 IgG and anti S1-RBD antibodies in a community outbreak
Mario Rassu
Clinical Chemistry and Laboratory Medicine (CCLM), 2021
View PDFchevron_right
Data on Anti-SARS-CoV-2 Antibodies (IgM/IgG) in COVID-19 Patients
Elena Claudia Coculescu
Romanian Journal of Legal Medicine
View PDFchevron_right
Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study
Olga Endrich
Authorea (Authorea), 2021
View PDFchevron_right
SARS-CoV-2 Antibodies Seroconversion in Healthcare Workers at a Tertiary Cancer Center
Hani Al-Najjar
2023
View PDFchevron_right
Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strain
noémie Verguet
Infection, 2021
View PDFchevron_right
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
Aron Hall
JAMA Internal Medicine, 2020
View PDFchevron_right
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
Julian A Villalba
The Journal of Infectious Diseases, 2020
View PDFchevron_right
Sero-surveillance of SARS-CoV-2 specific antibody (IgG) among garment workers in Bangladesh
Nazmul hossain
Research Square (Research Square), 2022
View PDFchevron_right
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
Advancement of SARS-CoV-2 infection in children
fuyong jiao
Pediatria polska, 2021
View PDFchevron_right
Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays
Sally Beer
2020
View PDFchevron_right
Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test
Simonetta Friso
Heliyon, 2021
View PDFchevron_right
Impact of SARS-CoV-2 exposure history on the T cell and IgG response
Marius Tincho
Cell reports medicine, 2023
View PDFchevron_right
Evaluation of the risk of SARS-CoV-2 infection and hospitalization in vaccinated and previously infected subjects based on real world data
Fabrizio Faggiano
Scientific Reports, 2023
View PDFchevron_right
SARS-CoV-2 IgG antibody responses in rt-PCR positive cases: first report from India
Usha Kiran Rout
View PDFchevron_right
Antibody Response to SARS-CoV-2 in Relation to the Contributing Factors in COVID-19 Patients
hafsa Aziz
Viral Immunology, 2022
View PDFchevron_right
A multicenter national survey of children with SARS-CoV-2 infection admitted to Spanish Pediatric Intensive Care Units
Cesar Villa Francisco
Intensive Care Medicine, 2020
View PDFchevron_right
Protective role of SARS-CoV-2 anti-S IgG against breakthrough infections among European healthcare workers during pre and post-Omicron surge—ORCHESTRA project
Giuseppe De Palma
Infection, 2024
View PDFchevron_right
Immune response against SARS-CoV-2 variants: the role of neutralization assays
Katarzyna Grzyb
npj vaccines, 2021
View PDFchevron_right
Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
Salma Younes
International Journal of Infectious Diseases, 2021
View PDFchevron_right
Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure
Claire Klaisner
JCI Insight, 2021
View PDFchevron_right
Evaluation an immunofluorescence-based antigen test for hospital point-of-care diagnosis of SARS-CoV-2 infection
Tandakha Dieye
Clinical Microbiology and Infectious Diseases, 2021
View PDFchevron_right
Levels of SARS-CoV-2 Lineage P.1 Neutralization by Antibodies Elicited after Natural Infection and Vaccination
Flavia Salles
SSRN Electronic Journal, 2021
View PDFchevron_right
Follow-up and comparative assessment of SARS-CoV-2 IgA, IgG, neutralizing, and total antibody responses after BNT162b2 or mRNA-1273 heterologous booster vaccination
Salma Younes
Authorea (Authorea), 2023
View PDFchevron_right
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
Flavia Salles
The Lancet Microbe, 2021
View PDFchevron_right
Antibody Response to SARS-CoV-2 Infection in Asymptomatic Bangladeshi Female Garment Workers
Tanjima Begum
European journal of medical and health sciences, 2023
View PDFchevron_right
Clinical characteristics of 51,815 patients presenting with positive and negative SARS-CoV-2 swab results in primary health care settings: Priority populations for vaccination
Ehab Hamed
Journal of Infection, 2021
View PDFchevron_right
Prevalence of IgG against SARS-CoV-2 and evaluation of a rapid MEDsan IgG test in children seeking medical care
Nicolas Vuilleumier
Clinical Infectious Diseases, 2020
View PDFchevron_right
Association of the Magnitude of Anti-SARS-CoV-2 Vaccine Side Effects with Sex, Allergy History, Chronic Diseases, Medication Intake, and SARS-CoV-2 Infection
siham al sinani
Vaccines, 2024
View PDFchevron_right
Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis
Ahmed Hossain
EClinicalMedicine, 2021
View PDFchevron_right
High but Short-lived anti-SARS-CoV2 neutralizing, IgM, IgA, and IgG levels among mRNA-vaccinees compared to naturally-infected participants
Salma Younes
medRxiv (Cold Spring Harbor Laboratory), 2022
View PDFchevron_right
Impact of Covishield Vaccination in Terms of SARS CoV-2 Neutralizing Antibody Expression
biby edwin
Indian Journal of Clinical Biochemistry
View PDFchevron_right
Population seroprevalence of SARS-CoV-2 antibodies in Anambra State, South-East, Nigeria
Ikenna Okoye
International Journal of Infectious Diseases, 2021
View PDFchevron_right
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
Naveenchandra Suryadevara
Cell Reports
View PDFchevron_right
MedicineSerologyPopulationVaccinationAsymptomaticTiter